HBK INVESTMENTS L P - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$365,000
-37.0%
9,600
-28.7%
0.00%
-33.3%
Q4 2018$579,000
+79.3%
13,463
+56.5%
0.01%
+200.0%
Q3 2017$323,000
+61.5%
8,600
+104.8%
0.00%
+100.0%
Q2 2017$200,000
-2.0%
4,200
+82.6%
0.00%
-66.7%
Q4 2014$204,0002,3000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders